- Category
- Micro (2022-23)
- Udyam number
- UDYAM-TS-09-0006226

About Suzen Medicare Private Limited
Data last updated:
Suzen Medicare Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 November 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2014PTC096481. Its GSTIN is 36AAVCS2093K2ZL (Telangana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹42 Cr and a paid-up capital of ₹29.76 Cr. It is led by directors including Shyamsunder Reddy Churukanti and Garima Agrawal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at General Park, Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.91 Cr, a growth of 82% compared to the previous year. For the same year it recorded a net profit of ₹8.5 Lakh (net margin 1.7%) and EBITDA of ₹4 Cr (EBITDA margin 81.4%). Revenue has grown at a compounded annual rate (CAGR) of 130% over three years.
The company is associated with 1 brand: Suzen Medicare. As per MCA filings, the company has open charges of ₹60 Cr on record.
Suzen Medicare Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-09-0006226). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website suzenmedicare.com.
Company details
Recognitions & Rankings of Suzen Medicare
Contact details
Suzen Medicare Private Limited's registered office is in Hyderabad, Telangana. Its website is suzenmedicare.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressTgiic Ltd E – City (Fab – City) General Park Sy No.30, Plot No.24/2 25/2 29/1 & 30/1 Raviryala Village Maheshwaram Mandal Ranga Reddy District, Hyderabad, Telangana, India – 501510
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Suzen Medicare Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Suzen Medicare operates one associated brand: Suzen Medicare. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing of IV fluids and injectable products following international standards in India. | suzenmedicare.com |
Financials of Suzen Medicare Private Limited
FY 2025 filings availableSuzen Medicare Private Limited reported revenue of ₹4.91 Cr (up 82% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 130% over three years, including 82% growth in the latest year. EBITDA rose 111% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹8.5 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 81.4% | ||||
| Net Profit Margin | 1.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Suzen Medicare Private Limited, buy the company report.
Board of directors of Suzen Medicare Private Limited
Suzen Medicare has 10 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shyamsunder Reddy Churukanti | Director | 17 Oct 2025 | 1 Years 0 Months | Current |
| Garima Agrawal | Director | 16 Mar 2016 | 10 Years 7 Months | Current |
| Manisha Reddy Patnam | Director | 17 Oct 2025 | 1 Years 0 Months | Current |
| Rineesh Reddy Patnam Also directs: Unicorn Hotels & Resorts LLP, Rineesh Hospitalities LLP, Rich Bioenergy Private Limited and 2 more | Director | 17 Oct 2025 | 1 Years 0 Months | Current |
| Sreenivas Reddy Patlolla | Director | 16 Mar 2016 | 10 Years 7 Months | Current |
| Suresh Babu Kotini | Director | 17 Oct 2016 | 10 Years 0 Months | Current |
Peer comparison
Suzen Medicare Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Reliv Healthcare Private Limited | ₹4.93 Cr (FY 2022) | -18.0% | Mumbai, Maharashtra, India | |||
| Cure Medicines (India) Private Limited | ₹4.93 Cr (FY 2025) | 10.0% | Pune, Maharashtra, India | |||
| Variety Pharmaceuticals Pvt Ltd | ₹4.92 Cr (FY 2025) | -11.0% | Palakkad, Kerala, India | |||
| La-Pharma(Gujarat) Private Limited | ₹4.91 Cr (FY 2025) | -6.0% | Ahmedabad, Gujarat, India | |||
| Subtle Pharmaceuticals Private Limited | ₹4.91 Cr (FY 2025) | 19.0% | Bangalore, Karnataka, India | |||
| Suzen Medicare Private Limitedthis company | ₹4.91 Cr (FY 2025) | ₹8.5 Lakh | 1.7% | 82.0% | Hyderabad, Telangana, India | |
| Arvind Remedies Limited | ₹4.89 Cr (FY 2017) | -66.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Suzen Medicare Private Limited, buy the company report.
Auditor
Suzen Medicare Private Limited is audited by Sankar& Raja for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Sankar& Raja | FY 2023 | 006601S |
Shareholding
The shareholding of Suzen Medicare Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Suzen Medicare Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 09 Feb 2023 | 100681411 | State Bank of India | ₹60 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Suzen Medicare Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Suzen Medicare Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Suzen Medicare has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAVCS2093K2ZL | Telangana | Active | 03 Oct 2017 |
To see the full GST registrations and return filing status of Suzen Medicare Private Limited, buy the company report.
Recent activity
Suzen Medicare Private Limited has 20 board changes on record since 2015: 10 appointments and 10 cessations. The latest: Jayender Reddy Annam was appointed as Director on 17 Oct 2025.
12 earlier events are in the company report.
Frequently asked questions
Suzen Medicare is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 November 2014 (12+ years old) and is registered under CIN U24232TG2014PTC096481.
Suzen Medicare has 10 current directors:
- Shyamsunder Reddy Churukanti - Director
- Garima Agrawal - Director
- Manisha Reddy Patnam - Director
- Rineesh Reddy Patnam - Director
- Sreenivas Reddy Patlolla - Director
- Suresh Babu Kotini - Director
- Jayender Reddy Annam - Director
- Yadagiri Reddy Boda - Director
- Sai Reddy Bekkera - Director
- Soumya Kondapalli - Director
The latest financial statements of Suzen Medicare on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Suzen Medicare is 36AAVCS2093K2ZL, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Suzen Medicare is U24232TG2014PTC096481. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Suzen Medicare was incorporated on 21 November 2014, making it 12+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Suzen Medicare by revenue are Reliv Healthcare Private Limited, Cure Medicines (India) Private Limited, Variety Pharmaceuticals Pvt Ltd, La-Pharma(Gujarat) Private Limited, Subtle Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Jayender Reddy Annam was appointed as Director on 17 Oct 2025. Manisha Reddy Patnam was appointed as Director on 17 Oct 2025. Rineesh Reddy Patnam was appointed as Director on 17 Oct 2025. Suzen Medicare has 20 board changes on record in total.
Yes, Suzen Medicare is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-09-0006226).
Suzen Medicare can be reached through the website suzenmedicare.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Suzen Medicare is at Tgiic Ltd E – City Fab – City General Park Sy No.30, Plot No.242 252 291 & 301 Raviryala Village Maheshwaram Mandal Ranga Reddy District, Hyderabad, Telangana, India – 501510.

